General Information of Disease (ID: DISVZUFT)

Disease Name Neuronal ceroid lipofuscinosis 7
Synonyms
CLN7 disease; CLN7 disease, late infantile; ceroid lipofuscinosis, neuronal, 7; CLN7; neuronal ceroid lipofuscinosis type 7; neuronal ceroid lipofuscinosis 7; neuronal ceroid lipofuscinosis caused by mutation in MFSD8; ceroid lipofuscinosis, neuronal, type 7; MFSD8 neuronal ceroid lipofuscinosis
Definition
Neuronal ceroid lipofuscinosis 7 (CLN7-NCL) is a rare condition that affects the nervous system. Signs and symptoms of the condition generally develop in early childhood (average age 5 years) and may include loss of muscle coordination (ataxia), seizures that do not respond to medications, muscle twitches (myoclonus), visual impairment, and developmental regression (the loss of previously acquired skills). CLN7-NCL is caused by changes (mutations) in the MFSD8 gene and is inherited in an autosomal recessive manner. Treatment options are limited to therapies that can help relieve some of the symptoms.
Disease Hierarchy
DIS9A4K4: Neuronal ceroid lipofuscinosis
DISI3RIL: Late infantile neuronal ceroid lipofuscinosis
DISVZUFT: Neuronal ceroid lipofuscinosis 7
Disease Identifiers
MONDO ID
MONDO_0012588
MESH ID
C563989
UMLS CUI
C1838571
OMIM ID
610951
MedGen ID
325457
Orphanet ID
228366

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 3 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
CLN5 OTY265P6 Strong Biomarker [1]
CLN8 OT0D4CB5 Strong Genetic Variation [2]
MFSD8 OT455EIC Definitive Autosomal recessive [3]
------------------------------------------------------------------------------------

References

1 Loss of CLN7 results in depletion of soluble lysosomal proteins and impaired mTOR reactivation.Hum Mol Genet. 2018 May 15;27(10):1711-1722. doi: 10.1093/hmg/ddy076.
2 Turkish variant late infantile neuronal ceroid lipofuscinosis (CLN7) may be allelic to CLN8.Eur J Paediatr Neurol. 2001;5 Suppl A:21-7. doi: 10.1053/ejpn.2000.0429.
3 Flexible and scalable diagnostic filtering of genomic variants using G2P with Ensembl VEP. Nat Commun. 2019 May 30;10(1):2373. doi: 10.1038/s41467-019-10016-3.